1
Total investments
0
Early stage
1
Mid stage
0
Late stage
7y
Years active
Portfolio
1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Sep 2019
DayTwo offers a sustainable path to remission for metabolic disease (diabetes, prediabetes, clinical obesity, non-alcoholic fatty liver disease) that uses gut microbiome sequencing, artificial intelligence, and virtual care.
After 10 years of scientific research, and the development of an AI-based algorithm that predicts blood sugar response to food, DayTwo’s virtual care solution reduces or eliminates medications by improving Time in Range and lowering A1C.
Experience · 2 entries
All (2)
Investments (1)
Board (1)
2019
Board Member
Sep 2019
DayTwo offers a sustainable path to remission for metabolic disease (diabetes, prediabetes, clinical obesity, non-alcoholic fatty liver disease) that uses gut microbiome sequencing, artificial intelligence, and virtual care.
After 10 years of scientific research, and the development of an AI-based algorithm that predicts blood sugar response to food, DayTwo’s virtual care solution reduces or eliminates medications by improving Time in Range and lowering A1C.
2018
L
Longliv Ventures Digital Health Fund
Managing Director
Jan 2018